4//SEC Filing
Flynn Paul R 4
Accession 0001093557-21-000213
CIK 0001093557other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:00 PM ET
Size
8.3 KB
Accession
0001093557-21-000213
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Flynn Paul R
EVP, Global Revenue
Transactions
- Sale
Common Stock
2021-09-10$558.33/sh−626$349,515→ 10,928 total - Sale
Common Stock
2021-09-09$541.36/sh−743$402,230→ 11,563 total - Sale
Common Stock
2021-09-09$541.76/sh−9$4,876→ 11,554 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Included in this number are 10,928 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
- [F3]On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850141
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 8:00 PM ET
- Size
- 8.3 KB